Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.345
-0.165 (-10.93%)
May 14, 2026, 3:32 PM EDT - Market open
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $93.6 million as of May 14, 2026. Its market cap has decreased by -67.90% in one year.
Market Cap
93.60M
Enterprise Value
174.47M
1-Year Change
-67.90%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $93.60M, a decrease of -79.86%. That is a compound annual growth rate of -18.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 105.08M | 11.18% |
| Dec 31, 2025 | 94.51M | 5.48% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AVITA Medical | 134.80M |
| Nano-X Imaging | 119.00M |
| Rapid Micro Biosystems | 118.08M |
| QT Imaging Holdings | 91.40M |
| MaxCyte | 88.08M |
| Outset Medical | 71.18M |
| LENSAR | 71.17M |
| Xtant Medical Holdings | 70.65M |